ArticleActive
Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A55147
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: October 1, 2024
Updated: December 31, 2025
Policy Summary
To bill the Cancer TYPE ID 92-gene assay, use CPT code 81540 and enter '1' in the Days/Unit field; include the appropriate DEX Z‑Code adjacent to the CPT code in the claim narrative using the specified electronic or paper fields (SV101-7/SV202-7, Loop 2400, Box 19, Block 80). Labs should submit identifier info via SV202-7 (preferred), SV101-7, or the NTE field, and must report an appropriate ICD-10-CM code; MolDX expects the test to be ordered only by the treating physician.
Coverage Criteria Preview
Key requirements from the full policy
"Bill Cancer TYPE ID using CPT code 81540 (mRNA gene expression assay of 92 genes) for evaluation of tumors of unknown origin."
Sign up to see full coverage criteria, indications, and limitations.